DEF 14A: Bain Capital Specialty Finance Seeks Stockholder Approval for Director Elections and Below-NAV Share Issuance

Sentiment:

Proxy Statement


Bain Capital Specialty Finance is holding its annual meeting to elect directors, seek authorization for below-NAV share issuance, and approve potential meeting adjournment.

Capital raiseThe company is seeking stockholder approval to renew authorization to sell shares of common stock below net asset value (NAV).The authorization would be effective for securities issued during a twelve-month period following Stockholder approval.The company may sell or otherwise issue shares of its Common Stock, not exceeding 25% of its then outstanding Common Stock, at a price below then-current NAV.

Summary

  • Bain Capital Specialty Finance, Inc. is holding its 2024 Annual Meeting of Stockholders on May 23, 2024, virtually.
  • Stockholders will vote on three proposals: electing three Class II Directors for a three-year term expiring in 2027, renewing authorization for the company to sell shares of common stock below the then-current net asset value (NAV) per share, and approving the adjournment of the Annual Meeting if necessary to solicit additional proxies.
  • The Board of Directors unanimously recommends voting for all three proposals.
  • The record date for determining stockholders eligible to vote is April 8, 2024.
  • The company has engaged Donnelley Financial Solutions (DFIN) for proxy solicitation at an estimated cost of $25,000, with printing and mailing costs estimated at $10,000.
  • As of the record date, 64,562,265.27 shares of common stock were outstanding.
  • The company is seeking authorization to sell shares below NAV, not exceeding 25% of outstanding common stock, during the next 12 months.
  • The company's independent registered public accounting firm is PricewaterhouseCoopers LLP.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and factual tone. The proposals are routine, and the Board's recommendations are clear, suggesting a stable outlook.

Positives

  • The Board is actively engaged, with all directors attending at least 75% of board and committee meetings in 2023.
  • The company has a clear process for stockholders to communicate with the Board.
  • The company has a resource sharing agreement with Bain Capital Credit to provide the Advisor with experienced investment professionals and access to resources.
  • The company has obtained exemptive relief from the SEC to permit greater flexibility to negotiate the terms of co-investments.

Negatives

  • Selling shares below NAV would result in immediate dilution to existing stockholders.
  • The company is dependent on its ability to raise capital through the issuance of its Common Stock.
  • Failure to maintain the required asset coverage ratio could have severe negative consequences for the Company, including the inability to pay dividends and breach of covenants in the Company's credit facility.

Risks

  • Market disruptions and instability may adversely affect the Company's access to sufficient debt and equity capital.
  • The debt capital that will be available, if any, may be at a higher cost and on less favorable terms and conditions in the future.
  • The company's ability to grow over time and to continue to pay dividends to Stockholders could be adversely affected if the Company were unable to access the capital markets as attractive investment opportunities arise.
  • Inability to access the capital markets could also have the effect of forcing the Company to sell assets that the Company would not otherwise sell and at disadvantageous times.

Future Outlook

The company seeks flexibility to raise equity capital to invest in attractive investment opportunities and maintain a favorable debt-to-equity ratio, especially during volatile market conditions.

Management Comments

  • Michael Ewald, Chief Executive Officer, thanks stockholders for their continued support.
  • The Board believes it is in the best interests of Stockholders to allow the Company flexibility to issue its Common Stock at a price below then-current NAV in certain instances.

Industry Context

As a BDC and RIC, Bain Capital Specialty Finance operates within specific regulatory and tax frameworks that influence its capital-raising and distribution strategies.

Comparison to Industry Standards

  • The document mentions that the Board considers data of comparable business development companies when determining Independent Director compensation.
  • The document mentions that the Advisor considers ESG factors throughout its investment decision-making process.

Related Party Transactions

  • The Advisor has entered into a resource sharing agreement with Bain Capital Credit.
  • The Company has entered into the Advisory Agreement with the Advisor.
  • The Company has entered into the Administration Agreement with the Advisor.
  • The Company may co-invest on a concurrent basis with other affiliates of Bain Capital Credit.

Stakeholder Impact

  • Stockholders will be directly impacted by the election of directors and the potential issuance of shares below NAV.
  • The company's ability to pay dividends could be affected by its ability to access the capital markets.
  • The company's employees and the Advisor's personnel are subject to codes of ethics and insider trading policies.

Next Steps

  • Stockholders are urged to vote on the proposals outlined in the proxy statement.
  • The company will hold its Annual Meeting on May 23, 2024, to vote on the proposals.
  • The Board will determine the final terms of any sale of common stock, including the nature and amount of consideration that would be received by the Company at the time of sale and the use of any such consideration.

Key Dates

DateDescription
April 8, 2024Record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting.
April 22, 2024Date of the Notice of 2024 Annual Meeting of Stockholders and Proxy Statement.
May 23, 2024Date of the 2024 Annual Meeting of Stockholders.
December 23, 2024Deadline for stockholders to submit proposals for inclusion in the 2025 proxy statement.
January 22, 2025Deadline for stockholders to submit proposals for the nomination of a director or other business at the 2025 Annual Meeting.
May 2025Expected date of the 2025 annual meeting of stockholders.

Keywords

proxy statement, annual meeting, directors, below-NAV share issuance, Bain Capital Specialty Finance, stockholders, common stock, investment company, BDC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.